Drug and Alcohol Dependence
Volume 105, Supplement 1 , Pages S56-S64, 1 December 2009

Risk management and post-marketing surveillance of CNS drugs

  • Jack E. Henningfield

      Affiliations

    • The Johns Hopkins University School of Medicine, Baltimore, MD 21229, USA
    • Pinney Associates, Bethesda, MD 20813, USA
    • Corresponding Author InformationCorresponding author at: Research and Health Policy, Pinney Associates, 3 Bethesda Metro Center, Bethesda, MD 20813, USA. Tel.: +1 301 718 8440; fax: +1 301 718 0034.
    • ,
  • Charles R. Schuster

      Affiliations

    • CRS Associates, LLC, Department of Psychiatry and Behavioral Neuroscience, Wayne State University School of Medicine, 1530 South State, Suite 900, Chicago, IL 60605, USA

Received 9 June 2009; received in revised form 20 August 2009; accepted 20 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0376-8716(09)00322-6

doi:10.1016/j.drugalcdep.2009.08.004

Drug and Alcohol Dependence
Volume 105, Supplement 1 , Pages S56-S64, 1 December 2009

Article Tools